Skip to main content
Veterinary Medicines

Vasotop P 0.625 mg tablets for dogs

Authorised
  • Ramipril

Product identification

Medicine name:
Vasotop P 0.625 mg tablets for dogs
Vasotop P 0,625 mg Tabletten für Hunde
Active substance:
  • Ramipril
Target species:
  • Dog
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Ramipril
    0.63
    milligram(s)
    /
    1.00
    Tablet
Pharmaceutical form:
  • Tablet
Withdrawal period by route of administration:
  • Oral use
    • Dog
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QC09AA05
Authorisation status:
  • Valid
Authorised in:
  • Austria
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Intervet Ges.m.b.H.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Intervet Ges.m.b.H.
Responsible authority:
  • Austrian Agency For Health And Food Safety
Authorisation number:
  • 8-00640
Date of authorisation status change:
Reference member state:
  • Netherlands
Procedure number:
  • NL/V/0245/001
Concerned member states:
  • Austria
  • Belgium
  • Germany
  • Greece
  • Ireland
  • Italy
  • Luxembourg
  • Norway
  • Spain

Documents

Labelling

This document does not exist in this language (English). You can find it in another language below.
German (PDF)
Published on: 22/01/2025

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
German (PDF)
Published on: 22/01/2025

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
German (PDF)
Published on: 22/01/2025

Combined File of all Documents

English (PDF)
Published on: 17/02/2025
Download

PuAR Vasotop P 0.625 mg-24-6.pdf

English (PDF)
Published on: 17/02/2025
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."